Furthermore, elevated levels of interleukin-17 (IL-17) have been observed in DM patients, and IL-17–producing T cells infiltrate the lesions of both psoriasis and DM, suggesting a contribution of the IL-23/Th17 axis to both diseases (6). This evidence concerns the gene IL17A and psoriasis.